| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
ADRA1D
|
adrenoceptor alpha 1D
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANGPT1
|
angiopoietin 1
|
|
APOE
|
apolipoprotein E
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
AVP
|
arginine vasopressin
|
|
BAX
|
BCL2-associated X protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BRD4
|
bromodomain containing 4
|
|
CA4
|
carbonic anhydrase IV
|
|
CABIN1
|
calcineurin binding protein 1
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNT1
|
cyclin T1
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CLU
|
clusterin
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTH
|
cystathionine gamma-lyase
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
E2F3
|
E2F transcription factor 3
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EP300
|
E1A binding protein p300
|
|
ESR1
|
estrogen receptor 1
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
FBN1
|
fibrillin 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOXO1
|
forkhead box O1
|
|
GATA4
|
GATA binding protein 4
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLRX3
|
glutaredoxin 3
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GYS2
|
glycogen synthase 2 (liver)
|
|
HDAC5
|
histone deacetylase 5
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HEY2
|
hes-related family bHLH transcription factor with YRPW motif 2
|
|
IER3
|
immediate early response 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL1B
|
interleukin 1, beta
|
|
ILK
|
integrin-linked kinase
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP2
|
Kv channel interacting protein 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LPL
|
lipoprotein lipase
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MOV10L1
|
Mov10 RISC complex RNA helicase like 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow
|
|
MYL7
|
myosin, light chain 7, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYLK3
|
myosin light chain kinase 3
|
|
MYOCD
|
myocardin
|
|
MYOZ2
|
myozenin 2
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NPY5R
|
neuropeptide Y receptor Y5
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRG1
|
neuregulin 1
|
|
NTS
|
neurotensin
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARVA
|
parvin, alpha
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
POMC
|
proopiomelanocortin
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PYGL
|
phosphorylase, glycogen, liver
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS3
|
regulator of G-protein signaling 3
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHOA
|
ras homolog family member A
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RRAD
|
Ras-related associated with diabetes
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100B
|
S100 calcium binding protein B
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC26A6
|
solute carrier family 26 (anion exchanger), member 6
|
|
SLC4A3
|
solute carrier family 4 (anion exchanger), member 3
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TFDP1
|
transcription factor Dp-1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
TGM2
|
transglutaminase 2
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TYR
|
tyrosinase
|
|
UCN
|
urocortin
|
|
VIP
|
vasoactive intestinal peptide
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
